Preprint
Article

This version is not peer-reviewed.

The Effects of Naringin on Growth Performance, Antioxidant Function, Intestinal Barrier and Immune Response in Broilers Challenged with Lipopolysaccharide

A peer-reviewed article of this preprint also exists.

Submitted:

30 August 2025

Posted:

01 September 2025

You are already at the latest version

Abstract
This study aimed to investigate the effects of naringin (NG) on growth performance, antioxidant status, intestinal barrier function, and immune stress in broilers challenged with lipopolysaccharide (LPS). A total of 144 one-day-old Arbor Acres broilers were randomly allocated into 2 treatment groups, with six replicates per group and 12 birds per replicate. The groups consisted of a control group (fed a basal diet) and a NG group (fed the basal diet supplemented with 200 mg/kg NG). The trial lasted 35 days, and body weight was recorded on the days 21 and 35 to evaluat growth performance. On day 21, two birds per replicate were intraperitoneally injected with 0.5 mg/kg body weight (BW) LPS, while another two birds received an equal volume of saline. Chickens were slaughtered 3 hours post-injection for sample collection. Dietary NG supplementation had no significant effect on the growth performance (p > 0.05). However, NG significantly mitigated the LPS-induced increases in plasma alanine aminotransferase (ALT) and alkaline phosphatase (ALP) levels, while attenuating the LPS-induced decreases in plasma total bilirubin (TB), triglyceride (TG), total cholesterol (TC), and low-density lipoprotein (LDL) levels (p < 0.05). NG supplementation significantly increased hepatic glutathione peroxidase (GSH-Px) activity, duodenal and ileal catalase (CAT) activity, and ileal GSH-Px activity. while reducing malondialdehyde (MDA) levels in the liver, duodenum, jejunum, and ileum, as well as hydrogen peroxide (H2O2) levels in the jejunum and ileum (p < 0.05). Dietary NG supplementation significantly upregulated the relative mRNA expression of Toll-like receptor 4 (TLR4) and interferon-gamma (IFN-γ) in the liver (p < 0.05) and attenuated the LPS-induced upregulation of tumor necrosis factor-alpha (TNF-α) mRNA expression in the jejunum (p < 0.05). NG reduced serum diamine oxidase (DAO) levels (p < 0.05), increased villus height in the duodenum and jejunum (p < 0.05), and increased the villus height to crypt depth (VH/CD) ratio in the jejunum (p < 0.05). Moreover, NG significantly upregulated the relative mRNA expression of zonula occludens-1 (ZO-1) and occludin in the duodenum, while significantly downregulating the relative expression of mucin-2 in the duodenum and ileum (p < 0.05). NG further reduced mucin-2 expression in the jejunum and mitigated the LPS-induced downregulation of ZO-1 in the ileum (p < 0.05). In addition, NG significantly upregulated the expression of X-linked inhibitor of apoptosis protein (XIAP) and B-cell lymphoma 2 (Bcl-2) and downregulated the expression of matrix metalloproteinase-13 (MMP-13) in the liver of LPS-challenged broilers (p < 0.05). conclusion,, dietary NG supplementation alleviated LPS-induced intestinal and hepatic injury in broilers. NG attenuated the adverse effects of LPS challenge on the intestinal barrier function and enhanced antioxidant capacity in broilers by modulating intestinal tight junction expression and .antioxidant enzyme activity, providing evidence for its potential application in broiler production.
Keywords: 
;  ;  ;  ;  

1. Introduction

Immune stress is common in modern intensive, high-density farming systems and hinders the healthy and sustainable development of the broiler industry, causing substantial economic losses annually. Immune stress refers to the physiological process whereby animals, in response to stimuli such as pathogen infection, vaccination, or environmental changes, activate their immune system and trigger non-specific physiological responses. These responses are often accompanied by cytokine release, metabolic disturbances, and reduced growth performance [1,2]. Among the consequences, the adverse impact on intestinal function is particularly critical. Studies have demonstrated that immune stress impairs the intestinal barrier integrity and significantly reduces digestive enzyme activity, leading to decreased nutrient absorption efficiency, while simultaneously inducing gut microbiota dysbiosis and systemic inflammatory responses [3,4]. Traditionally, antibiotics were added to feed to address this issue. However, with increasing increasing global concerns regarding food safety and quality, many countries have banned antibiotic use in animal feed. Consequently, bioactive plant-derived compounds, characterized by stable composition and high bioactivity, have emerged as a promising focus in the search for effective antibiotic alternatives.
Naringin (NG), a natural flavonoid and secondary metabolite predominantly found in the peels of citrus fruits such as pomelo, tangerine, and orange, has attracted considerable attention. NG exhibits multiple beneficial biological functions and possesses the advantages of non-toxicity, environmental friendliness, and sustainability, making it a promising candidate as a novel green feed additive in livestock production [5]. Li et al. [6] demonstrated that NG reduces the release of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) by inhibiting LPS-induced phosphorylation of MAPK (p38/JNK) and nuclear translocation of NF-κB, while also downregulating NADPH oxidase activity, reducing ROS levels, and mitigating oxidative stress. Zhang et al. [7] reported that NG elevates NADPH and GSH levels, decreases peroxynitrite levels, inhibits the expression of Pin1 (a pro-oxidative protein), and alleviates oxidative stress. Furthermore, in a mouse model of DSS-induced colitis, NG was shown to activate PPARγ, inhibit NF-κB nuclear translocation, reduce the secretion of TNF-α and IL-1β in colon tissue, and enhance intestinal barrier function [8].
Lipopolysaccharide (LPS), a major component of the outer membrane of Gram-negative bacteria (e.g., Escherichia coli and Salmonella), consists of lipid A (the toxic moiety), O-antigen, and core polysaccharides [9]. LPS binds to the CD14/TLR4/MD2 receptor complex on various cell types, triggering immunological stress, disrupting tight junctions in intestinal epithelial cells, compromising gut integrity, and induceing digestive disorders, growth retardation, and disease susceptibility, ultimately diminishing production efficiency [10,11]. The LPS-induced immune stress model exhibits high stability due to its well-defined pro-inflammatory mechanism, in which intracellular signaling cascades activate the key transcription factor NF-κB. NF-κB. translocates to the nucleus, where it promotes the synthesis and release of inflammatory cytokines (e.g., TNF-α, IL-6, and IL-1β). These mediators infiltrate target tissues, causing lipid metabolism dysregulation and tissue damage [12,13]. Luo et al. [14] reported that NG alleviated LPS-induced intestinal barrier damage in mice by inhibiting inflammatory factors. improving antioxidant function, and preserving intestinal tight junction integrity. Therefore, this study aimed to investigate the effects of NG on the growth performance of broilers under LPS-induced immune stress. These findings provide a scientific basis for the practical use of NG as a feed additive in poultry farming.

2. Materials and Methods

2.1. Animals and Experimental Design

All experimental procedures used were approved by the Institutional Animal Care and Use Committee of Wuhan Polytechnic University (protocol code: WPU202404003).
A total of 144 one-day-old Ross 308 broiler chicks with similar initial body weights were obtained from a commercial hatchery and randomly assigned to two groups. Each group consisted of six replicates with 12 birds per replicate (six males and six females). Birds in the control (CON) group were fed a corn–soybean meal basal diet, while birds in the NG group received the basal diet supplemented with 200 mg/kg NG. The basal diet was formulated according to the NY/T33-2004 recommendations for broilers, and its composition and nutrient levels are presented in Table 1. NG (purity ≥ 95%) provided by Hubei Horwath Biotechnology Co. (Hubei, China). The feeding trial lasted for 35 days. Broilers had ad libitum access to feed and water. The room temperature was maintained at 32~34℃ during the first week, then reduced by 3℃ per week until reaching 22℃, which was maintained thereafter. Relative humidity was controlled between 50~60% throughout the experiment.

2.2. Sample Collection

At 21 days of age, four broilers were randomly selected from each replicate. Two birds (one male and one female) were intraperitoneally injected with LPS (0.5 mg/kg body weight), while the other two received an equal volume of sterile saline. Three hours after injection, 2 mL of blood was collected from the wing vein into heparinized vacuum tubes. Samples were centrifuged at 3000 r/min for 10 min at 4℃, and plasma was separated, aliquoted into EP tubes, and stored at −80℃ for further analysis. Birds were then euthanized by cervical dislocation. The thymus, spleen, bursa of Fabricius, abdominal fat, and liver were excised and weighed. Liver samples were snap-frozen in liquid nitrogen and stored at −80℃. Segments of the duodenum, jejunum, and ileum (≈1 cm each) were fixed in 4% paraformaldehyde. Intestinal mucosa scrapings were collected, frozen in liquid nitrogen, and stored at −80℃ for subsequent analysis.

2.3. Growth Performance

Broilers in each replicate were weighed at 21 and 35 days of age, and feed intake was recorded during days 1–21, 21–35, and 1–35. Average body weight (BW), average daily gain (ADG), average daily feed intake (ADFI), and feed conversion ratio (FCR) were calculated per replicate.

2.4. Plasma Biochemical Parameters

Plasma biochemical parameters were measured using a HITACHI Automatic Analyzer (Model 7100, Tokyo, Japan). The following indicators were determined: total protein (TP), albumin (ALB), globulin (GLB), total bilirubin (TB), aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), γ-glutamyl transpeptidase (GGT), triglycerides (TG), total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), and lactate dehydrogenase (LDH).

2.5. Antioxidant Status

Approximately 1 g of liver, duodenum, jejunum, and ileum was homogenized in 9 mL of 0.9% ice-cold saline and centrifuged at 3500 × g for 15 min at 4℃. Supernatants were collected for antioxidant analysis. The levels of total antioxidant capacity (T-AOC), glutathione peroxidase (GSH-Px), total superoxide dismutase (T-SOD), catalase (CAT), hydrogen peroxide (H2O2), and malondialdehyde (MDA) in serum, liver, and intestinal tissues were determined using commercial kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China).

2.6. Serum Diamine Oxidase

Serum DAO concentration was determined using a commercial kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China), following the manufacturer’s instructions.

2.7. Intestinal Morphology

Intestinal segments (duodenum, jejunum, ileum; ≈1 cm) were fixed in 4% paraformaldehyde, dehydrated, cleared, embedded in paraffin, and sectioned at 3–5 μm thickness. Sections were stained with hematoxylin and eosin. Villus height (VH; from tip to villus–crypt junction), crypt depth (CD; from villus–crypt junction to base), villus width (VW), and villus area (VA) were measured according to a previous study [15]. Observations were performed using an Olympus BX-41TF microscope (Olympus, Japan). For each section, 10 intact villi were randomly selected, and VH, CD, and VA were measured using Olympus cellSens Standard software. The VH/CD ratio was calculated.

2.8. Transcription Level of Genes in the Liver and Intestine

Approximately 0.1 g of liver or intestinal tissue was placed in a 2 mL RNase-free tube, and 1 mL of Trizol reagent (Takara, Dalian, China) was added. Samples were homogenized at 4℃, and total RNA was extracted as described by Hou et al. [16]. RNA purity and concentration were determined using a NanoDrop® ND2000 spectrophotometer (Thermo Scientific, Wilmington, DE, USA). All samples were diluted to equal concentrations before reverse transcription using the HiScript III RT SuperMix kit (Takara, Dalian, China). Real-time quantitative PCR (qPCR) was performed using an ABI 7500 system (Applied Biosystems, Foster City, CA, USA) and Taq Pro Universal SYBR qPCR Master Mix (Takara, Dalian, China). The 10 μL reaction mixture contained 5 μL Master Mix, 1 μL cDNA (50 ng), 3.6 μL RNase-free water, and 0.2 μL of each primer (10 μmol/L). The program was: pre-denaturation at 95℃ for 30 s; 40 cycles of 95℃ for 5 s and 60℃ for 34 s. Melting curve analysis was performed at 95℃ for 15 s, 60℃ for 1 min, and 95℃ for 15 s. Gene expression levels were quantified using the 2-ΔΔCt method [18], with β-actin as the reference gene. Primer sequences are provided in Table 2.

2.9. Statistical Analysis

Growth performance data were analyzed using independent-sample t-tests in SPSS 27.0 (SPSS Inc., Chicago, IL, USA). Other data were analyzed by two-way ANOVA, followed by Duncan’s multiple range test for post hoc comparisons. Differences were considered statistically significant at p < 0.05.

3. Results

3.1. Growth Performance

As shown in Table 3, dietary supplementation with NG had no significant effect on BW, ADG, ADFI, or FCR of broilers during days 1–21, 22–35, or across the whole experimental period (p > 0.05).

3.2. Plasma Biochemical Parameters

According to Table 4, LPS challenge significantly increased plasma ALT and ALP activities, while reducing TP, ALB, TB, and GGT concentrations (p < 0.05). NG supplementation significantly increased plasma HDL levels (p < 0.05). Moreover, significant interactions between dietary NG and LPS injection were observed for TB, ALT, ALP, GGT, TG, TC, LDL, and LDH (p < 0.05). Specifically, NG supplementation reduced plasma ALT, ALP, and LDH, while increasing TB, TG, TC, and LDL levels in LPS-challenged broilers (p < 0.05).

3.3. Antioxidant Status

As shown in Table 5, LPS challenge significantly increased CAT and SOD activities but reduced plasma MDA concentrations (p < 0.05). Dietary NG alone significantly decreased plasma CAT activity (p < 0.05). A significant NG × LPS interaction was observed for plasma MDA (p < 0.05), with NG elevating MDA in unstimulated broilers (p < 0.05). In the liver, LPS significantly increased T-AOC and T-SOD activities while decreasing MDA (p < 0.05). NG × LPS interaction was also detected for hepatic GSH-Px activity (p < 0.05), with NG enhancing GSH-Px activity in unstimulated broilers (p < 0.05).
As shown in Table 6, LPS reduced CAT activity in the duodenum, whereas NG supplementation significantly increased CAT activity and reduced MDA levels (p < 0.05). In the jejunum, LPS significantly increased CAT activity and H₂O₂ concentrations (p < 0.05), while NG supplementation reduced both H2O2 and MDA (p < 0.05). A significant NG × LPS interaction was observed for jejunal T-SOD activity (p < 0.05), with NG increasing T-SOD in LPS-challenged broilers. In the ileum, LPS significantly increased H2O2 and MDA, while NG increased CAT and GSH-Px activities and reduced H₂O₂ and MDA (p < 0.05). Interactive effects of NG × LPS were found on ileal T-AOC, T-SOD, and GSH-Px (p < 0.05). Without LPS challenge, NG reduced ileal T-AOC and T-SOD (p < 0.05), whereas in LPS-challenged broilers, NG supplementation restored these indices.

3.4. Intestinal Barrier Function

As shown in Figure 1, NG supplementation significantly decreased serum DAO concentration (p < 0.05).
According to Table 7, NG supplementation significantly increased VH and VH/CD in the duodenum and jejunum (p < 0.05). A significant NG × LPS interaction was detected for duodenal CD and VH/CD (p < 0.05). In particular, NG improved VH/CD in LPS-challenged broilers.
As shown in Table 8, LPS significantly upregulated Claudin-1 expression in the jejunum and downregulated ZO-1 and Occludin expression in the duodenum (p < 0.05). NG supplementation upregulated ZO-1 and Occludin expression in the duodenum, while downregulating Mucin-2 in the duodenum and ileum (p < 0.05). NG × LPS interactions were observed for jejunal Mucin-2 and ileal ZO-1 expression (p < 0.05). In LPS-challenged broilers, NG upregulated ileal ZO-1 and downregulated ileal Mucin-2 expression (p < 0.05).

3.5. Immune Response

As shown in Table 9, LPS challenge significantly upregulated IL-1β, IL-8, iNOS, and TNF-α expression in the liver (p < 0.05). NG supplementation upregulated NF-κB expression (p < 0.05). NG × LPS interactions were observed for TLR4 and IFN-γ expression (p < 0.05). Without LPS challenge, NG increased TLR4 and IFN-γ expression, whereas in LPS-challenged broilers, NG reversed their expression.
As shown in Table 10, LPS upregulated IL-1β, IL-8, and IFN-γ in the duodenum; IL-1β, IL-8, TNF-α, and IFN-γ in the jejunum; and IL-1β, IL-8, TNF-α, NF-κB, and IFN-γ in the ileum (p < 0.05), while downregulating TLR4 in the duodenum. NG significantly downregulated IFN-γ in the jejunum (p < 0.05). An NG × LPS interaction was observed for jejunal TNF-α expression (p < 0.05), with NG reducing TNF-α expression under LPS challenge.
As shown in Table 11, LPS significantly increased MMP-9 and XIAP expression while decreasing MMP-13 and Bcl-2 expression in the liver (p < 0.05). NG supplementation increased XIAP and Bcl-2 expression (p < 0.05). NG × LPS interactions were observed for MMP-13 and Bcl-2 expression (p < 0.05). Specifically, under LPS challenge, NG further reduced hepatic MMP-13 expression.

4. Discussion

During broiler production, pathogenic infections, feed-derived toxins, and environmental stressors frequently induce immune stress, ultimately impairing growth performance and reducing economic efficiency [19]. LPS is commonly used to model immune stress due to its reproducibility, controllability, and well-characterized pro-inflammatory mechanisms [20]. Upon entering the host cell, LPS activates signaling cascades that drive nuclear translocation of NF-κB, resulting in the release of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β. These cytokines exacerbate lipid metabolism disorders and tissue damage [11,12]. Naringin (NG), a major bioactive flavonoid in citrus fruits, exhibits multiple biological activities, including antioxidant [21], anti-inflammatory [22], antitumor [23], hepatoprotective [24], and lipid-regulating effects [25]. However, studies evaluating its role in LPS-induced immune stress in broilers remain limited.
Previous reports demonstrated that NG improved growth and bone health in broilers with tibial dysplasia [26]. In contrast, our study showed that 200 mg/kg NG supplementation did not significantly influence growth performance across different stages. This discrepancy may relate to variations in basal diet composition, feeding duration, or bioactive compound content.
Biochemical parameters are sensitive indicators of organ function and metabolic state. In this study, LPS increased plasma ALT and LDH activities, consistent with liver injury, whereas NG supplementation mitigated these effects. This agrees with Ahmed et al. [27], who reported that NG alleviated chemically induced hepatotoxicity. Furthermore, LPS reduced TB, an endogenous antioxidant, while NG supplementation restored TB levels, suggesting enhanced antioxidative defense [28]. LPS also elevated ALP activity, indicating impaired digestive and metabolic regulation [29]. NG attenuated this response, further supporting its hepatoprotective role. Lipid metabolism was markedly altered by LPS, which decreased plasma TG, TC, and LDL. Notably, NG supplementation reversed these changes, highlighting its role in maintaining lipid transport and circulation homeostasis.
In the internal environment of organisms, the T-AOC serves as a comprehensive indicator reflecting the antioxidant potential of all antioxidant substances and enzymes in animals [30]. Both T-SOD and GSH-Px act as critical scavengers of oxygen-derived free radicals, effectively mitigating oxidative stress in the body [31]. The interaction between free radicals and lipid molecules induces lipid peroxidation, with MDA being a key terminal product of this process [32]. The CAT is a marker enzyme of peroxisomes, plays a pivotal role in the decomposition of H2O2 [33]. In vitro experiments have shown that NG significantly ameliorates the reduction in T-SOD, CAT, and GSH-Px activities induced by hypoxia/reoxygenation in H9C2 cells. Additionally, NG markedly decreases intracellular reactive oxygen species (ROS) and MDA levels, thereby reducing oxidative stress damage [34]. The current study demonstrates that, in plasma, LPS challenge significantly increased CAT and T-SOD activities while concurrently decreasing MDA levels. This finding contrasts with previous in vitro studies, where NG demonstrated antioxidant effects. The apparent discrepancy may be attributed to the systemic immune response induced by LPS, which could lead to compensatory upregulation of antioxidant enzymes to counteract the ROS burst associated with inflammation. However, NG supplementation resulted in a significant decrease in CAT activity and an increase in plasma MDA levels. This suggests that NG may inhibit the activity of plasma antioxidant enzymes under inflammatory conditions, potentially limiting the antioxidant capacity of the plasma. The results of redox indexes in the liver were similar to those in plasma. In the duodenum, NG supplementation alleviated the LPS-induced decrease in CAT activity and reduced MDA levels, indicating that NG has the potential to improve antioxidant defense in this region. In the jejunum, NG supplementation significantly reduced both H2O2 and MDA levels. Under LPS challenge, NG also significantly enhanced T-SOD activity, further supporting its role in modulating oxidative stress responses in the gastrointestinal tract. In the ileum, LPS stimulation significantly suppressed T-AOC, T-SOD, and GSH-Px activities, while increasing MDA contents. NG supplementation, however, effectively reversed these changes. NG enhanced CAT and GSH-Px activities while reducing both H2O2 and MDA levels. Collectively, these results suggest that NG may form an antioxidant defense barrier in the intestine by activating the glutathione system and enhancing the H2O2-scavenging capacity mediated by CAT. The marked reduction in intestinal MDA levels upon NG supplementation further underscores its targeted protective effect within the intestinal mucosal layer.
DAO is an intracellular enzyme predominantly found in the villus cells of the mammalian intestine. When the intestinal mucosa is compromised by external factors, the rupture of villus cells leads to the release of DAO into the bloodstream, causing elevated DAO levels. These elevated levels serve as a biomarker for the extent of intestinal mucosal damage [35]. In the present study, NG supplementation significantly reduced serum DAO levels in broilers, suggesting that NG enhances intestinal integrity and mitigates intestinal injury. Zhang et al. [36] reported that under LPS-induced stress conditions, broilers exhibited significantly decreased VH and VH/CD in the jejunum. In line with these findings, our study demonstrated that dietary NG supplementation significantly increased VH in both the duodenum and jejunum, as well as the VH/CD ratio in the jejunum. Notably, NG supplementation also markedly enhanced the duodenal VH/CD ratio under LPS challenge. These results collectively indicate that NG effectively ameliorates inflammation-induced villus atrophy and crypt hyperplasia, thereby contributing to the preservation of intestinal morphology and function.
The intestinal barrier consists of mechanical, immune, chemical, and microbial components. Tight junctions form junctional complexes that, together with epithelial cells, constitute the mechanical barrier [37]. Claudin-1 maintains and regulates cellular connections and intestinal defense, while occludin reduces permeability across cell membranes, effectively filtering both small and large molecules. ZO-1 is located on the cytoplasmic side of the cell membrane and links the tight junctions to the actin cytoskeleton [38]. Mucin, primarily secreted by goblet cells, covers the surface of intestinal mucosal cells, playing a key role in isolating harmful substances within the intestinal tract. Mucin-2, one of the most abundant mucins secreted by goblet cells, interacts dynamically with intestinal epithelial cells, the microbiota, and the host immune system to maintain intestinal mucosal homeostasis [39]. Cao et al. [40] demonstrated that NG could enhance the expression of ZO-1 and occludin in the colon of mice with DSS-induced ulcerative colitis. In alignment with their findings, our study revealed that dietary NG supplementation significantly upregulated ZO-1 expression in the duodenum, while downregulating Mucin-2 expression in both the duodenum and ileum. Under LPS challenge, NG supplementation markedly increased ZO-1 expression in the ileum and reduced Mucin-2 expression in the jejunum. The ileum-specific upregulation of ZO-1 and jejunum-specific suppression of Mucin-2 by NG may counteract LPS-induced oxidative stress via the Nrf2/KEAP1 pathway, while also inhibiting IFN-γ-driven mucus hypersecretion through suppression of the TLR4/IRF3 pathway. The coordinated upregulation of duodenal ZO-1 and downregulation of Mucin-2 suggests that NG promotes a ‘tight-junction-dominant’ barrier phenotype while inhibiting pathological mucus hyperplasia.
Alterations in the intestinal immune system can lead to changes in the intestinal mechanical barrier, with the homeostasis of this immune system playing a crucial role in both intestinal and systemic health [41]. Jiang et al. [42] reported that LPS challenge significantly upregulated the relative expression of IL-1β, IL-6, and TNF-α genes in the duodenum of broilers. In the present study, LPS stimulation notably increased the relative expression of IL-1β, IL-8, iNOS, and TNF-α in the liver; IL-1β, IL-8, and IFN-γ in the duodenum; IL-1β, IL-8, TNF-α, and IFN-γ in the jejunum; and IL-1β, IL-8, TNF-α, NF-κB, and IFN-γ in the ileum, while significantly downregulating duodenal TLR4 expression. These findings align with previous studies. Bi et al. [43] demonstrated that NG significantly downregulated the expression of IL-1, IL-6, TNF-α, and other inflammation-related proteins in LPS-induced human inflammatory vein endothelial cells. In the current study, NG effectively mitigated the LPS-induced upregulation of TNF-α expression in the jejunum, which is consistent with their core findings. NG also maintained baseline TLR4 expression levels, suggesting its potential to stabilize the TLR4-MD2 complex conformation or inhibit endocytic degradation pathways, thereby preserving innate immune recognition function. In jejunal tissue, NG significantly suppressed the overexpression of TNF-α and IFN-γ, consistent with established mechanisms by which flavonoids inhibit NF-κB nuclear translocation. Collectively, these results demonstrate that LPS stimulation drives pro-inflammatory gene expression, while NG counteracts the detrimental effects of LPS by attenuating such pro-inflammatory responses.
LPS is an endotoxin composed of lipids and polysaccharides that triggers excessive production of inflammatory factors, leading to immune stress and subsequent liver injury in animals [44]. The MMP-9 gene, a member of the matrix metalloproteinase (MMP) family, primarily functions in degrading collagen and other components of the extracellular matrix, facilitating tissue remodeling and cell migration [45]. MMP-13, another MMP family member, plays a key role in degrading cartilage matrix during skeletal development and remodeling, promoting cartilage extracellular matrix restructuring [46]. XIAP is the most potent endogenous inhibitor of apoptosis, while BCL-2 is an anti-apoptotic protein that mainly regulates the mitochondrial apoptosis pathway [47]. In the present study, LPS challenge significantly increased the relative expression of hepatic MMP-9, confirming LPS-induced liver injury in broilers. In contrast, LPS challenge downregulated hepatic MMP-13 expression. This suppression may reflect a dominance of acute-phase inflammation, as MMP-13-mediated collagen remodeling typically activates in later stages of tissue repair. Dietary NG supplementation significantly upregulated the relative expression of XIAP and BCL-2 in the livers of broilers, indicating NG’s anti-apoptotic protective effect against hepatic damage. These findings are consistent with NG’s ability to reduce plasma ALT levels under LPS challenge.

5. Conclusions

Dietary supplementation with NG alleviated LPS-induced liver and intestinal injury in broilers. NG modulated plasma biochemical markers, improved intestinal morphology, enhanced antioxidant enzyme activity, regulated tight junction protein expression, and reduced pro-inflammatory cytokine expression. Collectively, these findings suggest NG is a promising natural feed additive for protecting broilers against immune stress and enhancing intestinal health.

Author Contributions

Conceptualization, Y.H. and L.Y.; methodology, L.Y., S.G., L.T. and L.W.; validation, L.Y., L.T. and S.G.; formal analysis: L.Y., L.T., S.G. and L.W.; investigation, L.Y., Q.H., and L.W.; resources, L.Y., S.G., Q.H. and Y.H.; data curation, L.Y., L.T. and Y.H.; writing—original draft preparation, L.Y., L.T. and S.G.; writing-review and editing, L.Y., L.T., S.G., Q.H., L.W. and Y.H.; visualization, L.Y. and L.W.; supervision, S.G. and Y.H.; project administration, Q.H. and Y.H.; funding acquisition, Y.H. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by Hubei Important Science and Technology Project (2024BA004), the Hubei Provincial Key R&D Program (2023BBB040), and Youth Project of Hubei Natural Science Foundation (2023AFB354).

Institutional Review Board Statement

The animal study protocol was approved by the Institutional Animal Care and Use Committee of Wuhan Polytechnic University (protocol code: WPU202404003; approved on 18 April 2024).

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Gabler, N.K.; Spurlock, M.E. Integrating the immune system with the regulation of growth and efficiency. J. Anim. Sci. 2008, 86, 64–74. [Google Scholar] [CrossRef] [PubMed]
  2. Johnson, R.W. Inhibition of growth by pro-inflammatory cytokines: an integrated view. J. Anim. Sci. 1997, 75, 1244–1255. [Google Scholar] [CrossRef]
  3. Chen, X.; Zhang, L.; Wang, Y. Stress-sensitive neural circuits change the gut microbiome via duodenal glands. Cell. 2024, 435, 102–115. [Google Scholar] [CrossRef]
  4. Xu, D.; Gao, J.; Gillilland, M.; Wu, X.; Song, I.; Kao, J.Y.; Owyang, C. Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats. Gastroenterology. 2014, 146, 484–496. [Google Scholar] [CrossRef]
  5. Shilpa, V.S.; Shams, R.; Dash, K.K.; Pandey, V.K.; Dar, A.H.; Mukarram, S.A.; Harsányi, E.; Kovács, B. Phytochemical properties, extraction, and pharmacological benefits of naringin: A review. Molecules. 2023, 28, 5623. [Google Scholar] [CrossRef] [PubMed]
  6. Li, X.; Wang, Y.; Zhang, H.; et al. Naringin attenuates LPS-induced acute lung injury by suppressing NF-κB and MAPK signaling pathways. Biomed. Pharmacother. 2023, 158, 114567. [Google Scholar] [CrossRef]
  7. Zhang, R.L.; Wu, S.X.; Ye, T.; et al. In vivo metabolic effects of naringin in reducing oxidative stress and protecting the vascular endothelium in dyslipidemic mice. J. Nutr. Biochem. 2025, 15, 109865. [Google Scholar] [CrossRef]
  8. Peng, Y.; Qu, R.Y.; Xu, S.Q.; Bi, H.S.; Guo, D.D. Naringin suppresses ulcerative colitis via PPARγ/NF-κB axis. Heliyon. 2024, 10, e24619. [Google Scholar] [CrossRef]
  9. Randi L., G.; Steven T., R.; Thomas J., S. Border Control: Regulating LPS Biogenesis. Trends Microbiol. 2021, 29, 334–345. [Google Scholar] [CrossRef]
  10. Cao, S.T.; Zhang, Q.H.; Wang, C.C.; Wu, H.; Jiao, L.F.; Hong, Q.H.; Hu, C.H. LPS challenge increased intestinal permeability, disrupted mitochondrial function and triggered mitophagy of piglets. Innate Immun. 2018, 24, 221–230. [Google Scholar] [CrossRef]
  11. Zhang, L.Z.; Gong, J.G.; Li, J.H.; Hao, Y.S.; Xu, H.J.; Liu, Y.C.; Feng, Z.H. Dietary resveratrol supplementation on growth performance, immune function and intestinal barrier function in broilers challenged with lipopolysaccharide. Poult. Sci. 2023, 102, 102968. [Google Scholar] [CrossRef]
  12. Tanimura, N.; Saitoh, S.; Matsumoto, F.; Akashi-Takamura, S.; Miyake, K. Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling. Biochem. Biophys. Res. Commun. 2008, 368, 94–99. [Google Scholar] [CrossRef]
  13. Larrosa, M.; Azorín-Ortuño, M.; Yáñez-Gascón, M.J.; García-Conesa, M.T.; Tomás-Barberán, F.; Espín, J.C. Lack of effect of oral administration of resveratrol in LPS-induced systemic inflammation. Eur. J. Nutr. 2011, 50, 673–80. [Google Scholar] [CrossRef] [PubMed]
  14. Luo, D.Y.; Huang, Z.Q.; Jia, G.; Zhao, H.; Liu, G.M.; Chen, X.L. Naringin mitigates LPS-induced intestinal barrier injury in mice. F. & F. 2023, 14, 1617–1626. [Google Scholar] [CrossRef]
  15. Li, P.; Gao, M.K.; Fu, J.; Yan, S.J.; Liu, Y.F.; Mahmood, T.; Lv, Z.; Guo, Y.M. Dietary soya saponin improves the lipid metabolism and intestinal health of laying hens. Poult. Sci. 2022, 101, 101663. [Google Scholar] [CrossRef] [PubMed]
  16. Hou, Y.Q.; Wang, L.; Zhang, W.; Yang, Z.G.; Ding, B.Y.; Zhu, H.L.; Liu, Y.L.; Qiu, Y.S.; Yin, Y.L.; Wu, G.Y. Protective effects of N-acetylcysteine on intestinal functions of piglets challenged with lipopolysaccharide. Amino Acids. 2012, 43, 1233–1242. [Google Scholar] [CrossRef]
  17. Heid, C.A.; Stevens, J.; Livak, K.J.; Williams, P.M. Real time quantitative PCR. Genome Res. 1996, 6, 986–994. [Google Scholar] [CrossRef]
  18. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2−∆∆CT method. Methods. 2001, 25, 402–408. [Google Scholar] [CrossRef]
  19. Goo, D.; Kim, J.H.; Park, G.H. , Delos Reyes, J.B.; Kil, D.Y. Effect of Heat Stress and Stocking Density on Growth Performance, Breast Meat Quality, and Intestinal Barrier Function in Broiler Chickens. Animals. 2019, 9, 107. [Google Scholar] [CrossRef]
  20. Zhang, X.; Tian, X.; Wang, Y.; et al. Application of lipopolysaccharide in establishing inflammatory models. Int. J. Biol. Macromol. 2024, 279, 135371. [Google Scholar] [CrossRef] [PubMed]
  21. Renugadevi, J.; Prabu, S.M. Naringenin protects against cadmium-induced oxidative renal dysfunction in rats. Toxicology. 2009, 256, 128–134. [Google Scholar] [CrossRef]
  22. Shirani, K.; Yousefsani, B.S.; Shirani, M.; Karimi, G. Protective effects of naringin against drugs and chemical toxins induced hepatotoxicity: A review. Phytother. Res. 2020, 34, 1734–1744. [Google Scholar] [CrossRef]
  23. Bacanli, M.; Ba¸saran, A.A.; Ba¸saran, N. The major flavonoid of grapefruit: Naringin. In Polyphenols: Prevention and Treatment of Human Disease; Academic Press: Cambridge, MA, USA. 2018. [Google Scholar] [CrossRef]
  24. Pari, L.; Amudha, K. Hepatoprotective role of naringin on nickel-induced toxicity in male Wistar rats. Eur. J. Clin. Pharmacol. 2011, 650, 364–370. [Google Scholar] [CrossRef] [PubMed]
  25. Ren, B.; Qin, W.; Wu, F.H. , et al. Apigenin and naringenin regulate glucose and lipid metabolism, and ameliorate vascular dysfunction in type 2 diabetic rats. EUR J Pharmacol, 2016, 701, 1–10. [Google Scholar] [CrossRef]
  26. Jiang, X. , Li, A.Y., Wang, Y.P., et al. Ameliorative effect of naringin against thiram-induced tibial dyschondroplasia in broiler chicken. Environ. Sci. Pollut. Res. 2020, 27, 11337–11348. [Google Scholar] [CrossRef] [PubMed]
  27. Ahmed, O.M.; Fahim, H.I.; Ahmed, H.Y.; Al-Muzafar, H.M.; Ahmed, R.R.; Amin, K.A.; El-Nahass, E.-S.; Abdelazeem, W.H. The Preventive Effects and the Mechanisms of Action of Navel Orange Peel Hydroethanolic Extract, Naringin, and Naringenin in N-Acetyl-p-aminophenol-Induced Liver Injury in Wistar Rats. Oxid. Med. Cell. Longevity. 2019, 1–19. [Google Scholar] [CrossRef]
  28. Martelanc, M.; Žiberna, L.; Passamonti, S.; Franko, M. Direct determination of free bilirubin in serum at sub-nanomolar levels. Anal. Chim. Acta. 2014, 809, 174–182. [Google Scholar] [CrossRef]
  29. Zhu, X.; Wang, W.B.; Lu, J.; Hao, L.L.; Yang, H.X.; Liu, Y.J.; Si, F.C.; Kong, J.M. Grafting of polymers via ring-opening polymerization for electrochemical assay of alkaline phosphatase activity. Anal. Chim. Acta. 2021, 1185, 339069. [Google Scholar] [CrossRef]
  30. Ren, W.; Yin, Y.; Liu, G.; Yu, X.; Li, Y.; Yang, G.; Li, T.; Wu, G. Effect of dietary arginine supplementation on reproductive performance of mice with porcine circovirus type 2 infection. Amino Acids. 2012, 42, 2089–2094. [Google Scholar] [CrossRef]
  31. Kang, Z.W.; Liu, F.H.; Liu, X.; et al. The potential coordination of the heat-shock proteins and antioxidant enzyme genes of Aphidius gifuensis in response to thermal stress [J]. Front. Physiol. 2017, 8, 976. [Google Scholar] [CrossRef]
  32. Zhang, X.; Hou, L.C.; Guo, Z.; Wang, G.C.; Xu, J.T.; Zheng, Z.H.; Sun, K.; Guo, F.J. Lipid peroxidation in osteoarthritis: focusing on 4-hydroxynonenal, malondialdehyde, and ferroptosis. Cell Death Discov. 2023, 9, 320. [Google Scholar] [CrossRef]
  33. Sharma, K.; Choudhary, M.; Verma, K. Role of glutathione reductase and catalase enzyme in antioxidant defense mechanism in controlling fluoride-induced oxidative stress. J. Appl. Biol. Biotechnol. 2020, 8, 53–58. [Google Scholar] [CrossRef]
  34. Chen, R.C.; Sun, G.B.; Wang, J. , et al. Naringin protects against anoxia/reoxygenation -induced apoptosis in h9c2 cells via the Nrf2 signaling pathway. Food Funct. 2015, 6, 1331–1344. [Google Scholar] [CrossRef]
  35. Shi, L.T.; Li, Y.R.; Liu, Y.; Jia, H.Y. Alterations of gut microbiota and cytokines in elevated serum diamine oxidase disorder [J]. Medicine (Baltimore), 2022, 101, e31966. [Google Scholar] [CrossRef] [PubMed]
  36. Zhang, H.; Chen, Y.N.; Chen, Y.P.; Jia, P.L.; Ji, S.L.; Zhou, Y.M.; Wang, T. Dietary Pterostilbene Supplementation Attenuates Intestinal Damage and Immunological Stress of Broiler Chickens Challenged with Lipopolysaccharide. J. Anim. Sci. 2020, 98, skz373. [Google Scholar] [CrossRef] [PubMed]
  37. Johanna M.; Brandner; Proksch, E. Epidermal Barrier Function: Role of Tight Junctions. Book Skin Barrier. 2005, 20. [CrossRef]
  38. Wang, X.; Liu, Z.; Zhou, L.; Xu, M.; Dai, X.; Xiong, Y.; Zhang, H. Mosla Chinensis Extract Enhances Growth Performance, Antioxidant Capacity, and Intestinal Health in Broilers by Modulating Gut Microbiota. Microorganisms. 2024, 12, 2647. [Google Scholar] [CrossRef]
  39. Liu, Y.; Yu, X.; Zhao, J.; Zhang, H.; Zhai, Q.; Chen, W. The role of MUC2 mucin in intestinal homeostasis and the impact of dietary components on MUC2 expression. Int. J. Biol. Macromol. 2020, 164, 884–891. [Google Scholar] [CrossRef]
  40. Cao, R.G.; Wu, X.; Guo, H.; Pan, X.; Huang, R.; Wang, G.Q.; Liu, J.K. Naringin Exhibited Therapeutic Effects against DSS-Induced Mice Ulcerative Colitis in Intestinal Barrier–Dependent Manner. Molecules. 2021, 26, 6604. [Google Scholar] [CrossRef]
  41. Toh, T. S.; Chong, C.W.; Lim, S.Y.; Bowman, J.; Cirstea, M.; Lin, C.H.; Chen, C.C. , Appel-Cresswell, S.; Finlay, B.B.; Tan, A.H. Gut microbiome in Parkinson’s disease: New insights from meta-analysis. PARKINSONISM RELAT D. 2022, 94, 1–9. [Google Scholar] [CrossRef]
  42. Jiang, Y.; Zhang, W.H.; Gao, F.; Zhou, G.H. Effect of sodium butyrate on intestinal inflammatory response to lipopolysaccharide in broiler chickens. Anim. Sci. 2015, 95, 389–395. [Google Scholar] [CrossRef]
  43. Bi, C.; Jiang, Y.; Fu, T.; Hao, Y.; Zhu, X.; Lu, Y. Naringin inhibits lipopolysaccharide-induced damage in human umbilical vein endothelial cells via attenuation of inflammation, apoptosis and MAPK pathways. Cytotechnology. 2016, 68, 1473–1487. [Google Scholar] [CrossRef]
  44. Nakadate, K.; Saitoh, H.; Sakaguchi, M.; Miruno, F.; Muramatsu, N.; Ito, N.; Tadokoro, K.; Kawakami, K. Advances in Understanding Lipopolysaccharide-Mediated Hepatitis: Mechanisms and Pathological Features. CURR ISSUES MOL BIOL. 2025, 47, 79. [Google Scholar] [CrossRef]
  45. Pang, G.Y.; Ye,L. ; Jiang, Y.X.; Wu,Y.L.; Zhang, R.F.; Yang, H.X.; Yang, Y. Unveiling the bidirectional role of MMP9: A key player in kidney injury. Cell. Signal. 2024, 122, 111312. [Google Scholar] [CrossRef]
  46. Jiang, Y.; Liu, L.; Deng, Y.X.; Zhang, J.; Ye, A.H.; Ye, F.L.; He, B.C. MMP13 promotes the osteogenic potential of BMP9 by enhancing Wnt/β-catenin signaling via HIF-1α upregulation in mouse embryonic fibroblasts. Int. J. Biochem. Cell Biol. 2023, 164, 106476. [Google Scholar] [CrossRef]
  47. Chen, C.; Liu, T.S.; Zhao, C.S.; Yang, W.Z.; Chen, Z.P.; Yan, Y. XIAP impairs mitochondrial function during apoptosis by regulating the Bcl-2 family in renal cell carcinoma. Exp. Ther. Med. 2018, 15, 4587–4593. [Google Scholar] [CrossRef]
Figure 1. The effect of NG on serum DAO contents in broilers challenged with LPS. Data were presented with the means and SEM (n = 12). -LPS, injected with saline; +LPS, injected with LPS; -NG, fed basal diets; +NG, fed basal diets supplemented with 200 mg/kg NG.
Figure 1. The effect of NG on serum DAO contents in broilers challenged with LPS. Data were presented with the means and SEM (n = 12). -LPS, injected with saline; +LPS, injected with LPS; -NG, fed basal diets; +NG, fed basal diets supplemented with 200 mg/kg NG.
Preprints 174501 g001
Table 1. Ingredients and nutrient composition of basal diets.
Table 1. Ingredients and nutrient composition of basal diets.
Items
(%, Unless Otherwise Indicated)
1-21 Days of Age 22-35 Days of Age
Corn 51.73 57.68
Soybean meal (crude protein, 43.0%) 40.73 35.15
Soybean oil 3.36 3.66
Dicalcium phosphate 1.92 1.33
Limestone 1.16 1.26
Sodium chloride 0.35 0.35
DL-Methionine 0.26 0.13
Choline chloride (50%) 0.25 0.20
Multi-Minerals1 0.20 0.20
Multi-Vitamins2 0.04 0.04
Calculated nutrient levels
Crude protein 24.14 21.95
ME (MJ/kg) 12.22 12.56
Ca 1.15 0.99
Available P 0.62 0.48
Lysine 1.39 1.23
Methionine 0.60 0.45
Methionine + Cystine 0.96 0.79
Threonine 0.96 0.87
Tryptophan 0.27 0.24
1 The Multi-Minerals supplied the following per kilogram of diet: copper, 8 mg; iron, 80 mg; zinc, 75 mg; manganese, 100 mg; selenium, 0.15 mg; iodine, 0.35 mg. 2 The Multi-Vitamins supplied the following per kilogram of diet: vitamin A, 8,000 IU; vitamin D, 3,000 IU; vitamin E, 44 IU; vitamin K, 3.2 mg; vitamin B1, 3.0 mg; vitamin B2, 4.0 mg; vitamin B12, 0.025 mg; biotin, 0.0325 mg; folic acid, 2.00 mg; nicotinic acid, 15 mg; pantothenic acid, 15 mg.
Table 2. The primer sequences list1.
Table 2. The primer sequences list1.
Gene Name Primer Sequence (5′ to 3′) NCBI Number
β-Actin F:GAGAAATTGTGCGTGACATCA NM-205518.1
R:CCTGAACTCATTGCCA
Claudin-1 F:CATACTCCTGGGTCTGGTTGGT NM-001013611.2
R:GACAGCCATCCGCATCTTCT
ZO-1 F: CTTCAGGTGTTTCTCTTCCTCCTC XM-040680632.1
R:CTGTGGTTTCATGGCTGGATC
Occludin F:ACGGCAGCACCTACCTCAA NM-205128.1
R:GGGCGAAGAAGCAGATGAG
Mucin2 F:TTCATGATGCCTGCTCTTGTG NM-001318434.1
R:CCTGAGCCTTGGTACATTCTTGT
IFN-γ F:AGCTGACGGTGGACCTATTATT NM-205149.1
R:GGCTTTGCGCTGGATTC
TLR4 F:AGTCTGAAATTGCTGAGCTCAAAT NM-001030693.1
R:GCGACGTTAAGCCATGGAAG
IL-1β F:ACTGGGCATCAAGGGCTA NM-204524.1
R:GGTAGAAGATGAAGCGGGTC
IL-8 F:CGCTGTCACCGCTTCTTCA NM-205498.1
R:CGTCTCCTTGATCTGCTTGATG
iNOS F:CCTGTACTGAAGGTGGCTATTGG NM-204961.1
R:AGGCCTGTGAGAGTGTGCAA
NF-κB F:GTGTGAAGAAACGGGAACTG NM-205129.1
R:GGCACGGTTGTCATAGATGG
TNF-α F:CTGTGGGGCGTGCAGTG XM-040647309.1
R:ATGAAGGTGGTGCAGATGGG
MMP-13 F:TGGAACACTCCAGAGACCCT NM-002427.4
R:CTCTGTCTCCAGCACCATAGA
MMP-9 F:ATAGATGATGCCTTCCGGCG XM-06334928.1
R:CCATCACCATGCTCTTGGCT
BCL-2 F:GCTGCTTTACTCTTGGGGGT NM-205339.2
R:CTTCAGCACTATCTCGCGGT
XIAP F:AACCTGGTGATCGAGCTTGG XM-063346332.1
R:GTCCCGACCCAGGACAAAAA
Caspase-3 F:TGGTGGAGGTGGAGGAGC NM-204725.1
R:TGTCTGTCATCATGGCTCTTG
1 The primers were designed and synthesized by Shanghai Sangon Bioengineering Co., Ltd., Shanghai, China. Claudin-1, Occludin, and ZO-1 were tight junction proteins; IFN-γ, Interferon gamma; TLR4, Toll-like receptor 4; IL-1β, Interleukin-1β; IL-8, Interleukin-8; iNOS, Inducible nitric oxide synthase; NF-κB, Nuclear factor kappa-light-chain-enhancer of activated B cells; TNF-α, Tumor necrosis factor alpha; MMP-13, Matrix metalloproteinase-13; MMP-9, Matrix metalloproteinase-9; BCL-2, B-cell lymphoma 2; XIAP, X-linked inhibitor of apoptosis protein.
Table 3. The effect of NG on the growth performance of broilers1.
Table 3. The effect of NG on the growth performance of broilers1.
Items CON NG p-Value
Day 1 BW (g) 47.06±0.91 46.72±0.55 0.879
Day 21 BW (g) 949.28±48.84 971.84±41.50 0.614
Day 35 BW (g) 1849.31±53.10 1884.82±85.69 0.315
Days 1 to 21
ADG (g) 42.95±2.24 44.02±1.82 0.599
ADFI (g) 57.25±1.58 59.48±1.92 0.242
FCR 1.33±0.07 1.35±0.06 0.893
Days 22 to 35
ADG (g) 64.28±3.43 65.21±5.30 0.142
ADFI (g) 117.72±5.84 119.93±10.12 0.817
FCR 1.83±0.11 1.84±0.12 0.617
Days 1 to 35
ADG (g) 51.46±0.92 52.52±2.21 0.355
ADFI (g) 81.44±2.56 83.66±4.79 0.909
FCR 1.58±0.04 1.59±0.06 0.467
1 Data were presented with the means±SD (n = 6). CON, control; NG, naringin; BW, average body weight; ADG, average daily gain; ADFI, average daily feed intake; FCR, feed conversion ratio.
Table 4. The effect of NG on plasma biochemical parameters of broilers challenged with LPS1.
Table 4. The effect of NG on plasma biochemical parameters of broilers challenged with LPS1.
Items -LPS +LPS SEM p-Value
-NG +NG -NG +NG LPS NG LPS×NG
TP (g/L) 30.99 28.97 28.04 27.91 0.499 0.043 0.272 0.330
ALB (g/L) 12.92 12.76 11.95 11.47 0.177 0.001 0.330 0.617
GLB (g/L) 18.07 16.21 16.09 16.44 0.387 0.259 0.328 0.154
TB (μmol/L) 10.05a 8.77ab 6.38c 8.39b 0.292 <0.001 0.424 0.001
ALT (U/L) 2.41b 2.17b 3.09a 2.18b 0.118 0.031 0.720 <0.001
AST (U/L) 226.00 219.67 223.00 214.33 3.211 0.077 0.216 0.125
ALP (U/L) 3474.61b 3324.60b 4464.18a 2897.94b 159.281 0.321 0.004 0.015
GGT (U/L) 31.67a 19.83c 24.64b 23.67b 0.949 0.044 0.398 <0.001
TG (mmol/L) 0.47b 0.38c 0.33c 0.56a 0.017 0.445 0.005 <0.001
TC (mmol/L) 3.53a 3.28a 2.84b 3.47a 0.084 0.108 0.226 0.006
HDL (mmol/L) 2.09 2.28 1.93 2.21 0.044 0.268 0.025 0.615
LDL(mmol/L) 0.36b 0.35b 0.29b 0.53a 0.016 0.073 <0.001 <0.001
LDH (U/L) 596.99b 610.99b 728.71a 590.48b 12.893 0.112 0.077 0.032
a-c Means labeled with no common superscript in the same row differed significantly (p < 0.05).1Data were presented with the means and SEM (n = 12). -LPS, injected with saline; +LPS, injected with LPS; -NG, fed basal diets; +NG, fed basal diets supplemented with 200 mg/kg NG. TP, Total protein; ALB, albumin; GLB, globulin; TB, total bilirubin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; GGT, glutamyl transpeptidase; TG, triglycerides; TC, total cholesterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein; LDH, lactate dehydrogenase.
Table 5. The effect of NG on plasma and hepatic antioxidant status in broilers challenged with LPS1.
Table 5. The effect of NG on plasma and hepatic antioxidant status in broilers challenged with LPS1.
Items -LPS +LPS SEM p-Value
-NG +NG -NG +NG LPS NG LPS×NG
Plasma
T-AOC (mM) 1.76 1.77 1.84 1.78 0.013 0.069 0.257 0.143
CAT (U/mL) 8.99 2.53 18.17 12.49 0.978 <0.001 <0.001 0.614
GSH-Px (U/mL) 1,427.53 1,450.81 1,495.29 1,434.56 31.993 0.699 0.779 0.530
T-SOD (U/mL) 51.21 55.94 84.08 73.84 3.470 <0.001 0.640 0.208
H2O2 (mmol/L) 34.96 43.89 34.05 34.84 1.640 0.123 0.133 0.205
MDA (nmol/mL) 1.57b 4.18a 1.94 b 1.73b 0.188 <0.001 <0.001 <0.001
Liver
T-AOC (mmol/gprot) 1.28 1.25 1.43 1.40 0.017 <0.001 0.134 0.859
CAT (U/mgprot) 32.70 41.03 36.82 44.08 1.996 0.364 0.053 0.891
GSH-Px (U/mgprot) 424.25c 530.89b 644.54a 561.73ab 19.992 <0.001 0.715 0.006
T-SOD (U/mgprot) 285.91 298.34 336.44 372.18 9.317 <0.001 0.129 0.456
H2O2 (mmol/gprot) 58.87 53.07 51.58 53.97 1.478 0.286 0.567 0.173
MDA (nmol/mgprot) 4.28 4.70 2.46 3.69 0.262 0.004 0.082 0.384
a-c Means labeled with no common superscript in the same row differed significantly (p < 0.05). 1Data were presented with the means and SEM (n = 12). -LPS, injected with saline; +LPS, injected with LPS; -NG, fed basal diets; +NG, fed basal diets supplemented with 200 mg/kg NG. T-AOC, total antioxidant capacity; GSH-Px, glutathione peroxidase; T-SOD, total superoxide dismutase; CAT, catalase; H2O2, hydrogen peroxide and MDA, malondialdehyde.
Table 6. The effect of NG on intestinal antioxidant status in broilers challenged with LPS1.
Table 6. The effect of NG on intestinal antioxidant status in broilers challenged with LPS1.
Items -LPS +LPS SEM p-Value
-NG +NG -NG +NG LPS NG LPS×NG
Duodenum
T-AOC (mmol/gprot) 2.24 2.19 2.17 2.22 0.039 0.823 0.965 0.515
CAT (U/mgprot) 10.40 27.41 6.58 17.49 1.533 <0.001 <0.001 0.053
GSH-Px (U/mgprot) 194.85 219.57 227.89 137.78 21.334 0.578 0.456 0.195
T-SOD (U/mgprot) 154.71 173.15 172.89 159.83 4.718 0.798 0.777 0.104
H2O2 (mmol/gprot) 20.06 18.85 25.14 20.60 0.911 0.054 0.103 0.338
MDA (nmol/mgprot) 2.33 1.13 2.80 1.99 0.206 0.081 0.011 0.612
Jejunum
T-AOC (mmol/gprot) 0.70 0.69 0.69 0.71 0.009 0.702 0.908 0.293
CAT (U/mgprot) 3.84 3.97 4.99 5.61 0.199 <0.01 0.281 0.483
GSH-Px (U/mgprot) 238.48 192.44 224.75 263.48 13.000 0.273 0.888 0.108
T-SOD (U/mgprot) 94.93a 96.86a 76.95b 92.13a 4.286 0.064 0.005 0.002
H2O2 (mmol/gprot) 27.62 21.29 32.60 25.24 1.205 0.046 0.003 0.813
MDA (nmol/mgprot) 3.73 1.78 3.63 1.73 0.230 0.299 0.001 0.202
Ileum
T-AOC (mmol/gprot) 2.34a 1.80b 1.81b 1.91b 0.045 0.001 0.001 <0.001
CAT (U/mgprot) 3.26b 10.34a 3.17b 9.22a 0.703 0.424 <0.001 0.494
GSH-Px (U/mgprot) 84.50a 84.83a 60.29c 72.41bc 2.045 <0.001 0.022 0.029
T-SOD (U/mgprot) 62.21a 48.41b 52.39b 54.83b 1.429 0.495 0.027 0.002
H2O2 (mmol/gprot) 7.80 4.60 10.46 8.72 0.638 0.004 0.031 0.513
MDA (nmol/mgprot) 8.83a 4.60b 9.49a 9.33a 0.581 0.011 0.036 0.051
a,b,c Means labeled with no common superscript in the same row differed significantly (p < 0.05). 1Data were presented with the means and SEM (n = 12). -LPS, injected with saline; +LPS, injected with LPS; -NG, fed basal diets; +NG, fed basal diets supplemented with 200 mg/kg NG. T-AOC, total antioxidant capacity; GSH-Px, glutathione peroxidase; T-SOD, total superoxide dismutase; CAT, catalase; H2O2, hydrogen peroxide and MDA, malondialdehyde.
Table 7. The effect of NG on the intestinal morphology of broiler challenged with LPS1.
Table 7. The effect of NG on the intestinal morphology of broiler challenged with LPS1.
Items -LPS +LPS SEM p-Value
-NG +NG -NG +NG LPS NG LPS×NG
Duodenum
VH (μm) 1,094.23 1,206.62 1,058.86 1,323.60 31.797 0.425 0.001 0.145
CD (μm) 137.06b 179.73a 153.06ab 129.98b 5.982 0.081 0.298 0.002
VW (μm) 157.06 138.13 146.44 167.19 5.987 0.449 0.94 0.113
VA (μm2) 163,849.27 177,766.26 156,094.95 181,832.87 6,206.423 0.885 0.132 0.644
VH/CD 8.32b 6.90b 7.16b 10.29a 0.383 0.059 0.142 0.001
Jejunum
VH (μm) 1,060.68 1,367.86 1,083.80 1,325.52 43.367 0.890 0.001 0.637
CD (μm) 146.99 146.68 175.69 143.86 5.881 0.261 0.167 0.175
VW (μm) 126.93 126.10 148.01 125.42 3.613 0.129 0.084 0.107
VA (μm2) 142,396.87 175,103.10 149,210.97 169,502.83 7,390.928 0.967 0.086 0.677
VH/CD 7.37 9.41 6.27 9.48 0.400 0.395 <0.001 0.332
Ileum
VH (μm) 915.37 1,260.56 808.94 1,051.03 88.045 0.374 0.108 0.770
CD (μm) 148.00 126.56 137.18 132.04 4.488 0.770 0.157 0.377
VW (μm) 131.25 137.89 131.15 115.18 4.834 0.252 0.634 0.256
VA (μm2) 117,795.08 121,670.77 134,290.00 110,539.00 8,794.181 0.887 0.601 0.468
VH/CD 6.21 10.45 5.94 7.91 0.860 0.406 0.077 0.501
a-c Means labeled with no common superscript in the same row differed significantly (p < 0.05). 1Data were presented with the means and SEM (n = 12). -LPS, injected with saline; +LPS, injected with LPS; -NG, fed basal diets; +NG, fed basal diets supplemented with 200 mg/kg NG. VH, villus height; CD, crypt depth; VW, villus width; VA, villus area; VH/CD, the VH-to-CD ratio.
Table 8. The effect of NG on the relative expression levels of genes related to intestinal barrier function in broilers challenged with LPS1.
Table 8. The effect of NG on the relative expression levels of genes related to intestinal barrier function in broilers challenged with LPS1.
Items -LPS +LPS SEM p-Value
-NG +NG -NG +NG LPS NG LPS×NG
Duodenum
Claudin-1 1.00 1.15 0.93 1.25 0.060 0.932 0.054 0.481
Mucin-2 1.00 0.40 0.82 0.47 0.057 0.509 <0.001 0.150
ZO-1 1.00 1.26 0.81 1.08 0.038 0.004 <0.001 0.946
Occludin 1.00 1.37 0.80 0.85 0.055 <0.001 0.024 0.084
Jejunum
Claudin-1 1.00 0.97 1.33 1.33 0.061 0.005 0.873 0.905
Mucin-2 1.00a 0.31c 0.68b 0.41c 0.057 0.182 <0.001 0.011
ZO-1 1.00 0.95 1.05 1.08 0.036 0.239 0.910 0.593
Occludin 1.00 0.95 1.04 0.71 0.055 0.370 0.081 0.202
Ileum
Claudin-1 1.00 0.93 1.14 1.13 0.063 0.200 0.793 0.806
Mucin-2 1.00 0.64 0.84 0.67 0.044 0.413 0.002 0.230
ZO-1 1.00ab 0.92b 0.80b 1.19a 0.040 0.636 0.028 0.002
Occludin 1.00 1.07 0.96 1.10 0.053 0.932 0.324 0.750
a-c Means labeled with no common superscript in the same row differed significantly (p < 0.05). 1Data were presented with the means and SEM (n = 12). -LPS, injected with saline; +LPS, injected with LPS; -NG, fed basal diets; +NG, fed basal diets supplemented with 200 mg/kg NG. ZO-1, zonula occludens-1.
Table 9. The effect of NG on the relative expression levels of immune response related genes in broiler liver challenged with LPS1.
Table 9. The effect of NG on the relative expression levels of immune response related genes in broiler liver challenged with LPS1.
Items -LPS +LPS SEM p-Value
-NG +NG -NG +NG LPS NG LPS×NG
IL-1β 1.00 2.53 15.15 15.45 1.299 <0.001 0.558 0.694
IL-8 1.00 1.70 18.63 20.06 1.586 <0.001 0.520 0.825
INOS 1.00 1.29 13.18 17.55 1.412 <0.001 0.213 0.274
TNF-α 1.00 1.18 3.16 3.03 0.183 <0.001 0.907 0.474
NF-kB 1.00 1.31 1.20 1.44 0.058 0.131 0.016 0.764
TLR-4 1.00b 1.56a 0.65c 0.66c 0.077 <0.001 0.015 0.018
IFN-γ 1.00b 1.50a 0.86b 0.66b 0.077 <0.001 0.251 0.010
a-c Means labeled with no common superscript in the same row differed significantly (p < 0.05). 1Data were presented with the means and SEM (n = 12). -LPS, injected with saline; +LPS, injected with LPS; -NG, fed basal diets; +NG, fed basal diets supplemented with 200 mg/kg NG. IL-1β, Interleukin-1β; IL-8, Interleukin-8; iNOS, Inducible nitric oxide synthase; TNF-α, Tumor necrosis factor alpha; NF-κB, Nuclear factor kappa-light-chain-enhancer of activated B cells; TLR4, Toll-like receptor 4; IFN-γ, Interferon gamma.
Table 10. The effect of NG on the relative expression levels of immune response related genes in broiler intestine challenged with LPS1.
Table 10. The effect of NG on the relative expression levels of immune response related genes in broiler intestine challenged with LPS1.
Items -LPS +LPS SEM p-Value
-NG +NG -NG +NG LPS NG LPS×NG
Duodenum
IL-1β 1.00 1.13 2.38 3.29 0.227 <0.001 0.163 0.289
IL-8 1.00 0.80 3.44 4.23 0.313 <0.001 0.493 0.259
INOS 1.00 1.16 1.15 1.28 0.061 0.281 0.250 0.920
TNF-α 1.00 1.18 1.24 1.29 0.049 0.068 0.258 0.491
NF-kB 1.00 1.14 1.24 1.12 0.045 0.221 0.931 0.154
TLR-4 1.00 1.05 0.59 0.83 0.042 <0.001 0.033 0.159
IFN-γ 1.00 0.80 1.95 1.64 0.119 <0.001 0.196 0.781
Jejunum
IL-1β 1.00 1.49 2.96 2.12 0.231 0.004 0.669 0.118
IL-8 1.00 0.91 3.76 3.13 0.313 <0.001 0.491 0.606
INOS 1.00 0.92 1.66 1.19 0.135 0.088 0.305 0.465
TNF-α 1.00b 1.16ab 1.41a 1.07b 0.051 0.103 0.342 0.011
NF-kB 1.00 1.09 1.27 1.10 0.041 0.096 0.623 0.108
TLR-4 1.00 0.92 0.85 0.96 0.040 0.521 0.837 0.243
IFN-γ 1.00 0.80 2.75 1.77 0.153 <0.001 0.008 0.069
Ileum
IL-1β 1.00 0.84 2.64 2.55 0.200 <0.001 0.694 0.917
IL-8 1.00 1.06 1.96 1.97 0.176 0.008 0.925 0.932
INOS 1.00 0.84 1.53 1.30 0.133 0.067 0.454 0.890
TNF-α 1.00 0.87 1.13 1.25 0.044 0.003 0.971 0.137
NF-kB 1.00 1.13 1.26 1.51 0.055 0.002 0.057 0.537
TLR-4 1.00 1.06 0.97 1.30 0.057 0.332 0.091 0.233
IFN-γ 1.00 1.15 1.93 1.65 0.128 0.004 0.789 0.367
a-c Means labeled with no common superscript in the same row differed significantly (p < 0.05). 1Data were presented with the means and SEM (n = 12). -LPS, injected with saline; +LPS, injected with LPS; -NG, fed basal diets; +NG, fed basal diets supplemented with 200 mg/kg NG. IL-1β, Interleukin-1β; IL-8, Interleukin-8; iNOS, Inducible nitric oxide synthase; TNF-α, Tumor necrosis factor alpha; NF-κB, Nuclear factor kappa-light-chain-enhancer of activated B cells; TLR4, Toll-like receptor 4; IFN-γ, Interferon gamma.
Table 11. The effect of NG on the relative expression levels of liver injury related genes in broiler challenged with LPS1.
Table 11. The effect of NG on the relative expression levels of liver injury related genes in broiler challenged with LPS1.
Items -LPS +LPS SEM p-Value
-NG +NG -NG +NG LPS NG LPS×NG
MMP-13 1.00b 1.40a 0.60c 0.34d 0.088 <0.001 0.591 0.016
MMP-9 1.00 1.57 6.47 5.91 0.455 <0.001 0.989 0.276
XIAP 1.00 1.82 1.54 2.22 0.113 0.018 <0.001 0.722
BCL-2 1.00b 1.48a 0.73c 0.83bc 0.055 <0.001 <0.001 0.012
Caspase-3 1.00 1.24 0.87 1.04 0.057 0.145 0.069 0.759
a-c Means labeled with no common superscript in the same row differed significantly (p < 0.05). 1Data were presented with the means and SEM (n = 12). -LPS, injected with saline; +LPS, injected with LPS; -NG, fed basal diets; +NG, fed basal diets supplemented with 200 mg/kg NG. MMP-13, Matrix metalloproteinase-13; MMP-9, Matrix metalloproteinase-9; BCL-2, B-cell lymphoma 2; XIAP, X-linked inhibitor of apoptosis protein.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2025 MDPI (Basel, Switzerland) unless otherwise stated